Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Wilson

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Thorax|August 13, 2013
Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosisLudmila Shulgina, Anthony P Cahn, Edwin R Chilvers, et al.
Thorax|November 13, 2012
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trialLudmila Shulgina, Anthony P Cahn, Edwin R Chilvers, et al.
JAMA|December 8, 2020
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical TrialAndrew M Wilson, Allan B Clark, Tony Cahn, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 16, 2021
Predicting asthma-related crisis events using routine electronic healthcare data: a quantitative database analysis studyMichael Noble, Annie Burden, Susan Stirling, et al.
Thorax|September 4, 2012
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary careJane Rebecca Smith, Michael J Noble, Stanley Musgrave, et al.
Plos Medicine|October 15, 2020
Developing and validating subjective and objective risk-assessment measures for predicting mortality after major surgery: An international prospective cohort studyDanny J N Wong, Steve Harris, Arun Sahni, et al.
Clinical Biochemistry|October 28, 2009
Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factorsMichael D W Griffin, Leanne M Wilson, Yee-Foong Mok, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2024
<i>TOLLIP</i> SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary FibrosisWilliam Whalen, Kristin Berger, John S Kim, et al.
The Lancet. Respiratory Medicine|October 24, 2015
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort studyDavid B Price, Anna Rigazio, Jonathan D Campbell, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Thorax|August 13, 2013
Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosisLudmila Shulgina, Anthony P Cahn, Edwin R Chilvers, et al.
Thorax|November 13, 2012
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trialLudmila Shulgina, Anthony P Cahn, Edwin R Chilvers, et al.
JAMA|December 8, 2020
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical TrialAndrew M Wilson, Allan B Clark, Tony Cahn, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 16, 2021
Predicting asthma-related crisis events using routine electronic healthcare data: a quantitative database analysis studyMichael Noble, Annie Burden, Susan Stirling, et al.
Thorax|September 4, 2012
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary careJane Rebecca Smith, Michael J Noble, Stanley Musgrave, et al.
Plos Medicine|October 15, 2020
Developing and validating subjective and objective risk-assessment measures for predicting mortality after major surgery: An international prospective cohort studyDanny J N Wong, Steve Harris, Arun Sahni, et al.
Clinical Biochemistry|October 28, 2009
Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factorsMichael D W Griffin, Leanne M Wilson, Yee-Foong Mok, et al.
American Journal of Respiratory and Critical Care Medicine|May 19, 2024
<i>TOLLIP</i> SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary FibrosisWilliam Whalen, Kristin Berger, John S Kim, et al.
The Lancet. Respiratory Medicine|October 24, 2015
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort studyDavid B Price, Anna Rigazio, Jonathan D Campbell, et al.
Pageof 15